Furthermore, although the SAH stroke may stimulate the UCP-2 increase by a feedback regulation mechanism, the irisin treatment enhanced this promotion of UCP-2 in the SAH + irisin group (Figures 6B,E). Here, UCP2 is linked to stroke disorder.